The effect of esmolol infusion as an adjunct to total intravenous anesthesia on the total anesthetic and analgesic requirements in arthroscopic shoulder surgery

Elokda, Sherif A; Nasr, Ibrahim A

doi:10.4103/1687-7934.172741

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 3 , 4 ] Esmolol 1 mg/kg bolus over 60 s during preoxygenation is able to reduce the total induction dose by 18.5%. [ 11 , 12 ] Perioperative esmolol infusion has been shown to reduce the total anaesthetic and analgesic requirements and postoperative pain.…”

Section: Newer Drugs/combinations In Total Intravenous Anaesthesiamentioning

confidence: 99%

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology

Bajwa

Vinayagam

Shinde

et al. 2023

Indian Journal of Anaesthesia

View full text Add to dashboard Cite

Target-controlled infusion pumps and depth of anaesthesia monitors have made total intravenous anaesthesia (TIVA) easy, safe, and precise. The merits of TIVA were highlighted during the coronavirus disease 2019 (COVID-19) pandemic, confirming its potential further in the post-COVID clinical practice as well. Ciprofol and remimazolam are newer drugs that are being tried with a hope to upgrade the practice of TIVA. While research on safe and effective drugs continues, TIVA is being practised with a combination of drugs and adjuncts to overcome the disadvantages of each and to provide complete and balanced anaesthesia with additional benefits in recovery and pain relief postoperatively. Modulation of TIVA for the special population groups is still under process. Advancement in digital technology with mobile apps has increased the scope of TIVA in day-to-day use. The formulation and update of guidelines can establish a safe and efficient practice of TIVA.

show abstract

Section: Newer Drugs/combinations In Total Intravenous Anaesthesiamentioning

confidence: 99%

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology

Bajwa

Vinayagam

Shinde

et al. 2023

Indian Journal of Anaesthesia

View full text Add to dashboard Cite

show abstract

“…10,11 Esmolol 1 mg/kg bolus over 60 s during preoxygenation can reduce the total induction dose by 18.5%. 12,13 Perioperative esmolol infusion has been shown to reduce the total anaesthetic and analgesic requirements and postoperative pain. As research and development in anaesthesia continue, further advancements and novel intravenous agents are anticipated, potentially expanding the options available for TIVA and improving anaesthesia care.…”

Section: Intravenous Acetaminophenmentioning

confidence: 99%

Recent Advancements in Total Intravenous Anaesthesia (TIVA) and Anaesthetic Pharmacology

lone,

Dar

2023

Int J Health Sci Res

View full text Add to dashboard Cite

Total intravenous anaesthesia (TIVA) is an anaesthesia technique that exclusively employs intravenous agents for induction, maintenance, and emergence from anaesthesia, eliminating the need for inhalational agents. TIVA's principles, mechanisms, benefits, and emerging trends in anaesthetic pharmacology are discussed. Additionally, the challenges associated with TIVA implementation are explored. The article highlights the latest techniques, equipment, and novel intravenous agents used in TIVA, such as target-controlled infusion (TCI) systems, depth of anaesthesia monitoring, and new drugs like remimazolam, dexmedetomidine, and sugammadex. The article also emphasizes the potential benefits of TIVA, including improved hemodynamic stability, faster recovery, and reduced side effects. However, challenges such as cost, medication errors, and the learning curve of TCI systems are addressed. Furthermore, emerging trends in anaesthetic pharmacology, including opioid-sparing techniques, pharmacogenomics-based dosing, and novel analgesic agents, are discussed concerning their impact on TIVA practice. The integration of these advancements has revolutionized the field of anaesthesiology, offering clinicians safer and more precise anaesthesia delivery options. Ongoing research in anaesthetic pharmacology will continue to shape the future of TIVA, optimizing patient care and outcomes. Key words: Total intravenous anaesthesia, TIVA, anaesthetic pharmacology, advancements, intravenous agents, perioperative care..

show abstract

Esmolol as a Perioperative Opioid-Sparing Adjunct: Review of the Literature

Gilani¹,

Li²,

Ortiz³

2020

Topics in Pain Management

View full text Add to dashboard Cite

The effect of esmolol infusion as an adjunct to total intravenous anesthesia on the total anesthetic and analgesic requirements in arthroscopic shoulder surgery

Cited by 4 publications

References 0 publications

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology

Recent advancements in total intravenous anaesthesia and anaesthetic pharmacology

Recent Advancements in Total Intravenous Anaesthesia (TIVA) and Anaesthetic Pharmacology

Esmolol as a Perioperative Opioid-Sparing Adjunct: Review of the Literature

Contact Info

Product

Resources

About